Leaderboard Influence on Self-Regulated Training in a Gamified Dermoscopy Training App
NCT06254547 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2024-02-12
Summary
This study aims to examine the isolated effect of leaderboards (scoreboards) and daily training motivation on dermatology skill acquisition and training engagement within a gamified dermoscopy training platform.
Research Questions:
What is the effect of leaderboards and/or daily motivation on diagnostic accuracy? What is the effect of leaderboards and/or daily motivation on self-regulated learning: time spent training and case amount? What is the effect of leaderboards and/or daily motivation on training distribution?
Method:
150 danish medical students will upon inclusion and end of trial answer a Multiple Choice Questionnaire (MCQ).
Participants will be asked to download the gamified training platform onto their mobile devices. Within the app participants can access quizzes on a library of 10,000+ skin lesions combined with written educational modules on histopathological skin diagnosis. Participants receive instant feedback on quiz answered. Points are awarded for correct answers and removed for incorrect answers.
Participants will be randomized to one of three groups; either receiving no communication from the principal investigator, receiving a daily motivational message, or receiving a once daily updated leaderboard ranking participant's scores.
The intervention will last for seven days, followed by a 14-day washout period.
Conditions
- Melanoma (Skin)
- Skin Cancer
Interventions
- OTHER
-
Daily updated ranking on leaderboard
The intervention will last for seven days. Participants will on day two through seven receive a group daily message using an internet-based messaging service and view a daily updated leaderboard ranking. Leaderboards will demonstrate participant's ranking in their respective group, participant's (anonymized) name, cumulative point total, total case amount, and current level. Participant ranking will be based on the cumulative point total. All groups will have continual access to their personal score. Participants will not receive further training encouragement to train in the app or interact with the research group beyond this, aside from technological aid.
- OTHER
-
Daily motivational message
The intervention will last for seven days. Participants will on day two through seven receive a group daily message using an internet-based messaging service encouraging training. Participants will not receive further training encouragement to train in the app or interact with the research group beyond this, aside from technological aid.
Sponsors & Collaborators
-
Herlev Hospital
lead OTHER
Principal Investigators
-
Martin Frendø, MD, PhD · Copenhagen Academy for Medical Education and Simulation
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-01-27
- Primary Completion
- 2024-02-25
- Completion
- 2024-03-03
Countries
- Denmark
Study Locations
More Related Trials
-
Assessment of Dermatologists at Skin of Color Clinics
NCT03201029 ·Status: COMPLETED
-
A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo
NCT06319781 ·Status: RECRUITING
-
The Acquisition of Blood and Skin Samples From Normal Volunteers to Support Research Activities on Dermatologic Diseases
NCT00001505 ·Status: COMPLETED
-
Chester Step Test: is It Effective in Scleroderma Patients?
NCT06859567 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
6-minute Pegboard Ring Test in Patients with Scleroderma
NCT06588959 ·Status: NOT_YET_RECRUITING
-
Digital Toolkit for Skin Diseases in LMICs: Part 2
NCT06292260 ·Status: RECRUITING ·Phase: NA
-
Prevalence and Subjective Impairment of Quality of Life (QoL) Due to Dermatologic Diseases in Internal Medicine Patients
NCT01044043 ·Status: COMPLETED
-
Non-invasive Imaging for In-vivo Quantification of Skin Composition and Structure
NCT06976073 ·Status: RECRUITING
-
A Comparison Between Two Educational Methods in the Rehabilitation of the Microstomia in Systemic Sclerosis
NCT03766243 ·Status: COMPLETED ·Phase: NA
-
Delving Into Participation Trends of Scleroderma Clinical Trials
NCT06264492 ·Status: NOT_YET_RECRUITING
-
Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component)
NCT03253666 ·Status: COMPLETED
-
Artificial Intelligence Patient App for RDEB SCCs
NCT05843994 ·Status: ACTIVE_NOT_RECRUITING
-
Tissue and Serum Level of NLRP1, NLRP3 and Il-18 in Early Stages of mf Patients
NCT06066554 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of Aesthetic Impact in Patients With Systemic Sclerosis
NCT03271320 ·Status: COMPLETED
-
Evaluation and Treatment of Patients With Dermatologic Diseases
NCT00001506 ·Status: COMPLETED
-
Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers
NCT00001164 ·Status: COMPLETED
-
Optical Elastography of Systemic Sclerosis Skin
NCT02835196 ·Status: COMPLETED
-
Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine
NCT02465476 ·Status: COMPLETED ·Phase: NA
-
Deciphering the Vitiligo Transcriptomic Signature Between Repigmented and Non Repigmented Lesions
NCT05927272 ·Status: RECRUITING ·Phase: NA
-
Microvascular and Fibrosis Imaging Study
NCT01758250 ·Status: COMPLETED
-
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
NCT00368784 ·Status: COMPLETED
-
Gasdermin D Expression in Generalized Vitiligo Patients After Narrow-band Ultraviolet B Therapy
NCT06546059 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Patient Reported Outcomes With UVA-1 Therapy for Treatment of Sclerosing Skin Diseases
NCT04922736 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effects of Telerehabilitation Based Exercise Program in Patients With Systemic Sclerosis
NCT05078749 ·Status: UNKNOWN ·Phase: NA
-
Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial
NCT02349009 ·Status: COMPLETED ·Phase: PHASE1/PHASE2